Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use

Advanced pancreatic cancer results in high morbidity and mortality. The standard of care treatment in the advanced setting changed in 2011 with the introduction of FOLFIRINOX (FFX) chemotherapy. However, it was highly toxic with significant risk of complications. We assessed the practice patterns of...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Joanna Gotfrit, Horia Marginean, Yoo-Joung Ko, Akmal Ghafoor, Petr Kavan, Haji Chalchal, Shahid Ahmed, Karen Mulder, Patricia Tang, Rachel Goodwin
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Subjects:	FOLFIRINOX advanced pancreatic cancer clinical practice practice patterns prescribing
Online Access:	https://www.mdpi.com/1718-7729/32/3/128